End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.175 CAD | +45.83% | +29.63% | -61.11% |
Feb. 23 | Mydecine Innovations Closes Partial Debt Settlement | MT |
Feb. 02 | Mydecine Innovations Group Inc Announces Resignation of Neil Stevenson-Moore as Director | CI |
Chart calendar Mydecine Innovations Group Inc.
Upcoming events on Mydecine Innovations Group Inc.
Past events on Mydecine Innovations Group Inc.
2024-03-28 | Q4 2023 Earnings Release (Projected) |
2023-11-15 04:49 am | Q3 2023 Earnings Release |
2023-08-14 08:32 pm | Q2 2023 Earnings Release |
2023-07-03 | Extraordinary Shareholders Meeting |
2023-05-16 04:01 pm | Q1 2023 Earnings Release |
2023-05-04 | Annual General Meeting |
2023-03-31 08:21 pm | Q4 2022 Earnings Release |
2022-08-15 09:46 pm | Interim 2022 Earnings Release |
2022-07-20 | Annual General Meeting |
2022-05-16 09:28 pm | Q1 2022 Earnings Release |
2022-03-31 08:53 pm | FY 2021 Earnings Release |
2022-03-27 | Maxim Growth Conference |
2021-12-05 | H.C. Wainwright Psychedelics Conference |
2021-11-10 07:30 pm | Horizons Veterans & Families Forum - Panel |
2021-11-07 | Microdose Wonderland Miami Meeting - One on One |
2021-09-22 03:00 pm | M-Vest Maxim Group Advances in Mental Health Virtual Conference - Panel |
2021-09-22 10:00 am | Maxim Group and M-Vest Advances in Mental Health Virtual Conference - Panel |
2021-09-21 | Maxim Group and M-Vest Advances in Mental Health Virtual Conference |
2021-09-21 01:15 pm | Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit |
2021-09-20 02:00 pm | Annual General Meeting |
Annual results
Fiscal Period | December | 2020 | 2021 |
---|---|---|---|
Net sales Million CAD | Released Forecast Spread | 0,06 | 0,01 0,06 -88.3% |
EBITDA Million CAD | Released Forecast Spread | 0,00 | -25,0 -23,5 -6.5% |
EBIT Million CAD | Released Forecast Spread | 0,00 | -28,7 -26,1 -9.97% |
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | 0,00 | -28,9 -22,7 -27.22% |
Net income Million CAD | Released Forecast Spread | -26,9 | -28,9 -22,7 -27.22% |
EPS CAD | Released Forecast Spread | 0,00 | -6,00 -4,75 -26.32% |
Announcement Date | 30/04/21 | 31/03/22 |
Quarterly results
Fiscal Period | December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 |
---|---|---|---|---|---|
Net sales Million CAD | Released Forecast Spread | 0,00 0,04 -99.82% | -0,01 0,09 -115.32% | 0,00 0,30 - | |
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | -4,54 -5,03 9.77% | -10,9 -5,02 -116.76% | -5,64 -5,94 5.01% | |
Net income Million CAD | Released Forecast Spread | -4,54 -5,03 9.77% | -10,9 -5,02 -116.76% | -5,64 -5,94 5.01% | |
EPS CAD | Released Forecast Spread | -1,00 -0,50 -100% | -2,00 -1,00 -100% | -1,20 -1,00 -20% | -0,35 |
Announcement Date | 15/11/21 | 31/03/22 | 16/05/22 | 15/08/22 |
Past sector events for Mydecine Innovations Group Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MYCOF Stock
- MYCO Stock
- Calendar Mydecine Innovations Group Inc.